Want to see KR:004080 full AI Analyst Report?
Shinhung Co., Ltd (004080) AI Stock Analysis
Shinhung Co., Ltd
(Korea Exchange:004080)
The score is primarily constrained by negative TTM operating and free cash flow despite improved revenue and margins, which reduces earnings quality and visibility. A conservatively levered balance sheet provides stability, while technicals are neutral-to-slightly constructive. Valuation is moderate-to-premium (P/E ~24) with a modest dividend yield, limiting upside if cash generation does not normalize.
Shinhung Co., Ltd (004080) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- KRW 133.78B
- Dividend Yield
- 2.42%
- Average Volume (3M)
- 5,460
- Price to Earnings (P/E)
- 24.4
- Beta (1Y)
- 0.00
- Revenue Growth
- 7.30%
- EPS Growth
- 17.00%
- Country
- KR
- Employees
- 208
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
Shinhung Co., Ltd Business Overview & Revenue Model
Company Description
Operating primarily in South Korea, Shinhung Co., Ltd. specializes in the production and distribution of a comprehensive array of dental goods and supplies. Their extensive product line features sophisticated implant systems and related components, e...
Shinhung Co., Ltd Financial Statement Overview
Summary
Income statement trends improved with a sharp TTM revenue rebound and higher margins, and the balance sheet remains conservatively levered. However, TTM operating cash flow and free cash flow are negative, which materially weakens earnings quality and increases near-term funding/working-capital risk.
Income Statement
63PositiveBalance Sheet
78PositiveCash Flow
34Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 105.89B | 102.61B | 101.76B | 112.44B | 118.18B | 126.85B |
| Gross Profit | 33.03B | 31.95B | 30.93B | 36.04B | 34.76B | 37.03B |
| EBITDA | 11.36B | 9.27B | 10.09B | 15.29B | 13.65B | 23.61B |
| Net Income | 5.36B | 2.82B | 5.23B | 9.23B | 8.46B | 13.45B |
Balance Sheet | ||||||
| Total Assets | 157.24B | 149.63B | 141.43B | 140.33B | 140.62B | 138.61B |
| Cash, Cash Equivalents and Short-Term Investments | 1.61B | 1.83B | 6.10B | 9.17B | 8.46B | 6.91B |
| Total Debt | 17.33B | 11.27B | 3.99B | 8.90B | 7.48B | 6.80B |
| Total Liabilities | 39.86B | 33.63B | 25.27B | 26.44B | 33.76B | 37.20B |
| Stockholders Equity | 116.71B | 115.40B | 115.67B | 113.89B | 106.86B | 101.42B |
Cash Flow | ||||||
| Free Cash Flow | -5.59B | -1.59B | 5.65B | 1.66B | 960.02M | 974.29M |
| Operating Cash Flow | -2.17B | 1.93B | 9.58B | 7.64B | 4.42B | 3.34B |
| Investing Cash Flow | 324.84M | -5.13B | -3.63B | -7.39B | -4.87B | 14.90B |
| Financing Cash Flow | 2.28B | 3.51B | -7.20B | -449.50M | -2.60B | -12.58B |
Shinhung Co., Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:004080, the sentiment is Positive. The current price of 14480.00 is above the 20-day moving average (MA) of 14379.50, above the 50-day MA of 14258.40, and above the 200-day MA of 13859.99, indicating a bullish trend. The MACD of 32.95 indicates Positive momentum. The RSI at 61.08 is Neutral, neither overbought nor oversold. The STOCH value of 47.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KR:004080.
Shinhung Co., Ltd Peers Comparison
Overall Rating
- KR:00408058Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| KR:004080 | 58Neutral | KRW 132.51B | 24.44 | ― | 2.42% | 7.30% | 17.00% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| KR:004080 | Shinhung Co., Ltd | 14480.00 | 1180.70 | 8.88% | |
| KR:032620 | GC MediAI Corporation | 2815.00 | -681.35 | -19.49% | |
| KR:226590 | MDEVICE Co., Ltd | 9520.00 | -7770.00 | -44.94% | |
| KR:240550 | Dongbang Medical Co., Ltd. | 5020.00 | -4160.00 | -45.32% | |
| KR:394420 | RecensMedical, Inc. | 5150.00 | -13300.00 | -72.09% | |
| KR:418550 | JEIO Co., Ltd. | 4050.00 | -4520.00 | -52.74% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026